Markets Leerink cuts American Renal to MP but ups PT to $27 Leerink downgraded American Renal Associates (NYSE:ARA) to “market perform” but raised its price target to $27 from $17, citing a fuller valuation after the company reported fourth quarter results. The stock closed at... March 8, 2018